| Antiviral Therapy | |
|---|---|
| Abbreviated title (ISO) | Antivir Ther, AVT |
| Discipline | Antivirals |
| Language | English |
| Publication details | |
| Publisher | International Medical Press (UK) |
| Publication history | 1996–present |
| Frequency | 8 per year |
| Open access | after 12 months |
| Impact factor (2009) |
4.32 |
| Indexing | |
| ISSN | 1359-6535 |
| Links | |
Antiviral Therapy is a peer-reviewed academic journal published by International Medical Press, London, UK. It publishes primary papers and reviews on all aspects of the clinical development of antivirals, including clinical trial results, resistance, viral diagnostics, drug safety, pharmacoepidemiology and vaccines. Antiviral Therapy is an official publication of the International Society for Antiviral Research.
The journal was founded in 1996 by Douglas D. Richman (University of California, San Diego, La Jolla, USA) and Joep M.A. Lange (University of Amsterdam, The Netherlands), who still as of 2010 serve as the joint Editors-in-Chief. The first two issues were published by MediTech Media Ltd.[1] The initial publication frequency was quarterly, rising to bimonthly in 2003 and to eight issues a year in 2005. The journal also publishes supplements containing abstracts from various conferences and workshops, including the International HIV Drug Resistance Workshop, International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV and Therapies for Viral Hepatitis Workshop.
Articles from 1998 are archived online in PDF format, with content over a year old being free. All online content is available free to those living in developing countries.
The journal had an impact factor of 4.32 in 2009.[2] It is indexed by Chemical Abstracts, Current Contents (Clinical Medicine), EMBASE/Excerpta Medica, Medline/Index Medicus, Research Alert and SciSearch.